Home »
Rulemaking » Prospective Grants of Exclusive Licenses: Development of Cannabinoid(s) and Cannabidiol(s) Based Therapeutics to Treat Hepatic Encephalopathy in Humans
Prospective Grants of Exclusive Licenses: Development of Cannabinoid(s) and Cannabidiol(s) Based Therapeutics to Treat Hepatic Encephalopathy in Humans
Prospective Grants of Exclusive Licenses: Development of Cannabinoid(s) and Cannabidiol(s) Based Therapeutics to Treat Hepatic Encephalopathy in Humans
Details Information
Comments
Related Documents